• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab.

作者信息

Zielecki Piotr, Kaniewska Magdalena, Furmanek Mariusz, Bulski Tomasz, Rydzewska Grażyna

机构信息

Clinical Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland.

Department of Radiology, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland.

出版信息

Prz Gastroenterol. 2020;15(3):267-272. doi: 10.5114/pg.2020.99042. Epub 2020 Sep 19.

DOI:10.5114/pg.2020.99042
PMID:33005274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7509907/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/7b9135ef27e3/PG-15-41798-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/9785450be653/PG-15-41798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/877eb7d5c0dd/PG-15-41798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/d74dc6ad016b/PG-15-41798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/7b9135ef27e3/PG-15-41798-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/9785450be653/PG-15-41798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/877eb7d5c0dd/PG-15-41798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/d74dc6ad016b/PG-15-41798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9048/7509907/7b9135ef27e3/PG-15-41798-g004.jpg

相似文献

1
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab.托珠单抗有效治疗重症急性胰腺炎和新型冠状病毒肺炎。
Prz Gastroenterol. 2020;15(3):267-272. doi: 10.5114/pg.2020.99042. Epub 2020 Sep 19.
2
Effects of Tocilizumab on Experimental Severe Acute Pancreatitis and Associated Acute Lung Injury.托珠单抗对实验性重症急性胰腺炎及其相关急性肺损伤的影响。
Crit Care Med. 2016 Aug;44(8):e664-77. doi: 10.1097/CCM.0000000000001639.
3
Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.托珠单抗治疗重型和危重型新型冠状病毒肺炎患者的临床疗效
World J Clin Cases. 2020 Sep 6;8(17):3763-3773. doi: 10.12998/wjcc.v8.i17.3763.
4
Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series.托珠单抗的早期使用可能预防部分新冠患者的临床病情恶化：病例系列研究
Cureus. 2020 Jul 14;12(7):e9187. doi: 10.7759/cureus.9187.
5
Efficacy of tocilizumab treatment in cerulein-induced experimental acute pancreatitis model in rats.托珠单抗治疗大鼠雨蛙肽诱导的实验性急性胰腺炎模型的疗效。
Turk J Gastroenterol. 2017 Nov;28(6):485-491. doi: 10.5152/tjg.2017.16738. Epub 2017 Oct 25.
6
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.用于治疗新型冠状病毒肺炎细胞因子风暴的抗白细胞介素-6单克隆抗体
Ann Thorac Med. 2020 Jul-Sep;15(3):171-173. doi: 10.4103/atm.ATM_286_20. Epub 2020 Jun 18.
7
Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy.心脏-肾脏移植患者感染新型冠状病毒肺炎，在免疫抑制维持治疗基础上加用托珠单抗进行治疗。
Int J Cardiol Heart Vasc. 2020 Jul 17;29:100596. doi: 10.1016/j.ijcha.2020.100596. eCollection 2020 Aug.
8
The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series.白细胞介素-6抑制剂在新型冠状病毒肺炎感染治疗中的作用：病例系列
Cureus. 2020 Jun 15;12(6):e8631. doi: 10.7759/cureus.8631.
9
Suspected case of COVID-19-associated pancreatitis in a child.一名儿童疑似新型冠状病毒肺炎相关胰腺炎病例。
Radiol Case Rep. 2020 Aug;15(8):1309-1312. doi: 10.1016/j.radcr.2020.06.009. Epub 2020 Jun 6.

引用本文的文献

1
Effects of individualized comprehensive nutritional support on inflammatory markers, serum amylase (AMS), prealbumin (PA), albumin (ALB), calcium ion (Ca2+) in patients with severe pancreatitis.个体化综合营养支持对重症胰腺炎患者炎症指标、血清淀粉酶（AMS）、前白蛋白（PA）、白蛋白（ALB）、钙离子（Ca2+）的影响。
J Med Biochem. 2024 Nov 16;43(6):843-852. doi: 10.5937/jomb0-48944.
2
Occam's razor or Hickam's dictum-COVID-19 is not a textbook aetiology of acute pancreatitis: A modified Naranjo Score appraisal.奥卡姆剃刀或希卡姆定律——COVID-19 不是急性胰腺炎的典型病因：改良 Naranjo 评分评估。
World J Gastroenterol. 2023 Apr 7;29(13):2050-2063. doi: 10.3748/wjg.v29.i13.2050.
3

本文引用的文献

1
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.托珠单抗治疗重症新型冠状病毒肺炎患者：一项回顾性队列研究
Lancet Rheumatol. 2020 Aug;2(8):e474-e484. doi: 10.1016/S2665-9913(20)30173-9. Epub 2020 Jun 24.
2
Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.北加利福尼亚州有胰腺炎病史患者中新冠病毒病的患病率、危险因素及临床结局
Gut. 2021 Feb;70(2):440-441. doi: 10.1136/gutjnl-2020-321772. Epub 2020 Jun 3.
3
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.
Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?
2019冠状病毒病（COVID-19）患者的胃肠道症状——是友还是敌？
Prz Gastroenterol. 2022;17(3):219-226. doi: 10.5114/pg.2021.111000. Epub 2021 Nov 18.
4
Hyperlipidemia, COVID-19 and acute pancreatitis: A tale of three entities.高脂血症、COVID-19 和急性胰腺炎：三者之间的故事。
Am J Med Sci. 2022 Sep;364(3):257-263. doi: 10.1016/j.amjms.2022.03.007. Epub 2022 Apr 4.
5
Insights into Acute Pancreatitis Associated COVID-19: Literature Review.关于急性胰腺炎合并新型冠状病毒肺炎的见解：文献综述
J Clin Med. 2021 Dec 16;10(24):5902. doi: 10.3390/jcm10245902.
6
Association between acute pancreatitis and COVID-19 infection: What do we know?急性胰腺炎与新型冠状病毒肺炎感染之间的关联：我们了解些什么？
World J Gastrointest Surg. 2021 Jun 27;13(6):548-562. doi: 10.4240/wjgs.v13.i6.548.
ACE2 在胰腺中的表达可能导致 SARS-CoV-2 感染后的胰腺损伤。
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2128-2130.e2. doi: 10.1016/j.cgh.2020.04.040. Epub 2020 Apr 22.
4
Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.接受托珠单抗治疗的COVID-19患者的急性高甘油三酯血症
J Med Virol. 2020 Oct;92(10):1791-1792. doi: 10.1002/jmv.25907. Epub 2020 Jun 3.
5
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.《中国 2019 年冠状病毒病（COVID-19）的临床特征：系统评价和荟萃分析》
J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.
6
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征：白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
7
Covid-19 and the digestive system.Covid-19 与消化系统。
J Gastroenterol Hepatol. 2020 May;35(5):744-748. doi: 10.1111/jgh.15047. Epub 2020 Apr 19.
8
Evidence for Gastrointestinal Infection of SARS-CoV-2.新型冠状病毒2019（SARS-CoV-2）胃肠道感染的证据。
Gastroenterology. 2020 May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055. Epub 2020 Mar 3.
9
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
10
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.